futibatinib
otsuka
['futibatinib', 'taiho']
taiho oncology announces updated efficacy and safety data for futibatinib in cholangiocarcinoma at 2022 asco annual meeting 
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.